Workshop Date and Time

Wednesday, June 13, 2018, 4:00 – 5:00 pm, Eastern Time Register Now

Registrants can listen in live over the phone or online as a webcast.

Topics Covered

  • Overview of Marginal Zone Lymphoma, including Staging & Location
  • Subtypes of Marginal Zone Lymphoma
  • Review of Treatment Options
  • Treatment for Relapsed/Refractory Marginal Zone Lymphoma
  • Managing Treatment Side Effects
  • Key Questions to Ask Your Health Care Team
  • The Important Role of Clinical Trials
  • How Research Contributes to Your Treatment Options
  • Follow-Up Care
  • Quality-of-Life Concerns
  • Questions for Our Panel of Experts

Our Panel of Experts

David J. Straus, MD

Attending Physician, Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Professor of Clinical Medicine, Weill Cornell Medical College

Carolyn Messner, DSW, OSW-C, FAPOS

Director of Education and Training, CancerCare

Continuing Education Credits

Live Only

Social Workers: This program has been submitted to the University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.

Cancer Care, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.

Registered Dietitians: This program has been submitted to the Commission on Dietetic Registration for one Continuing Professional Education Unit (CPEU).

To request continuing education paperwork, please email your name, profession, and address to connect@cancercare.org after the program. All paperwork for continuing education credit must be requested, completed, and submitted within two weeks of the live program.

Brochure

You can download the brochure for this workshop(pdf)(79 KB)

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top